Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q2 EPS of ($0.38), $0.05 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.